XRN EBITDA Growth
52.35%TTM
Period ending:
XRN TTM EBITDA YoY %%
15473.88%-18986.41%
2013-08-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
XRN ebitda growth history
Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 50 observations from Aug 31, 2013 to Jun 30, 2026.
| Period ending | EBITDA Growth |
|---|---|
| 52.3465% | |
| -7.4298% | |
| 2.3332% | |
| 13.2769% | |
| 14.3214% | |
| -0.4458% | |
| -9.8628% | |
| -15.0608% | |
| -12.1581% | |
| -5.3762% | |
| 6.9522% | |
| 14.3289% | |
| 16.5292% | |
| 18.8696% | |
| 12.5764% | |
| 14.5433% | |
| 18.9697% | |
| 24.3047% | |
| 29.4697% | |
| 28.0942% | |
| 27.3222% | |
| 24.0349% | |
| 26.6913% | |
| 32.1571% | |
| 32.0248% | |
| 33.477% | |
| 31.5412% | |
| 35.7573% | |
| 47.8653% | |
| 73.014% | |
| 127.012% | |
| 248.7517% | |
| 626.5705% | |
| 1,263.4516% | |
| 7,037.4341% | |
| 1,619.3411% | |
| 337.0344% | |
| 2,403.69% | |
| -57.672% | |
| -29.0298% | |
| 54.556% | |
| -122.9276% | |
| 2,167.1311% | |
| 544.1415% | |
| 12,139.0167% | |
| 2,011.2378% | |
| 264.4152% | |
| -2,319.5955% | |
| -15,651.5464% | |
| 1.5261% |
Compare ebitda growth
All XRN financial metrics · XRN stock overview · How to interpret financial metrics
